Galecto, Inc. (GLTO)
NASDAQ: GLTO · Real-Time Price · USD
24.99
+1.69 (7.25%)
At close: Jan 14, 2026, 4:00 PM EST
24.51
-0.48 (-1.92%)
After-hours: Jan 14, 2026, 5:59 PM EST
Galecto Market Cap
Galecto has a market cap or net worth of $39.86 million as of January 14, 2026. Its market cap has increased by 458.46% in one year.
Market Cap
39.86M
Enterprise Value
32.33M
1-Year Change
458.46%
Ranking
Category
Stock Price
$24.99
Market Cap Chart
Since the IPO on October 29, 2020, Galecto's market cap has decreased from $368.78M to $39.86M, a decrease of -89.19%. That is a compound annual growth rate of -34.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 37.17M | 1.26% |
| Dec 31, 2025 | 36.70M | 499.36% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |